A Prospective, Non-Randomized Pivotal Clinical Investigation to Demonstrate the Safety and Performance of the TrueCross Single-Use Microcatheter
Coronary Artery Disease Obliterative, Chronic Total Occlusion (CTO)
About this trial
This is an interventional treatment trial for Coronary Artery Disease Obliterative focused on measuring microcatheter, CTO, coronary artery disease, PCI
Eligibility Criteria
Inclusion Criteria: i. Subjects who are >25 years of age. ii. Subjects who are able/willing to provide a written informed consent prior to participating in the clinical investigation. iii. The subject is male or, if female, is either not of childbearing potential or must use effective contraception during participation in this Clinical Investigation. iv. Subject suffering from coronary artery disease requiring percutaneous coronary angiography and/or intervention. v. Lesions classified as CTOs, meaning, TIMI 0 flow within the occluded segment and angiographic or clinical evidence or high likelihood of an occlusion duration > 3 months vi. Reference vessel diameter ≥2 mm. Exclusion Criteria: i. Coronary angiography and/or intervention contraindications. ii. Subjects with severe arrhythmia. iii. Subjects with severe systemic infection. iv. Subjects with severe coagulation disorder. v. Subjects with severe heart failure, unstable decompensated heart failure, congestive heart failure, or dyspnea who are unable to lie supine on the examination table for angiography. vi. Subjects with prior coronary artery spams or prior heart valve replacement. vii. Currently participating in an investigational drug or another device clinical investigation that has not completed the primary endpoint or that clinically interferes with the current clinical investigation endpoints.
Sites / Locations
- Israeli-Georgian Medical Research Clinic Ltd - Healthycore Clinic
- Tbilisi Heart and Vascular Clinic
- Tbilisi Institute of Medicine
- Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic
- Onassis Heart Surgery Centre
- Red Cross General Hospital
- National Heart Centre Singapore
Arms of the Study
Arm 1
Experimental
TrueCross microcatheter
The TrueCross Single-use Microcatheter will be used in percutaneous coronary intervention(PCI) of the enrolled subjects.